Everyday Health price target raised to $22 from $18 at Stifel Stifel increased its price target on Everyday Health as the firm thinks the company continues to benefit from strong biopharmaceutical advertising trends. The firm believes that the company obtained new sponsors for its Everyday Solutions section throughout Q2. It keeps a Buy rating on the shares.
Everyday Health outlook has improved, says SunTrust After meeting with Everyday Health's management, SunTrust says it is confident in the company's long-term outlook, and thinks its acquisition of DoctorDirectory was solid and can generate revenue synergies. SunTrust keeps a Buy rating on the shares.